It was developed by Syrrx , a company which was acquired by Takeda Pharmaceutical Company in 2005 .
In April 2016 , the U.S. FDA added a warning about increased risk of heart failure .
FDA was developed by Syrrx , a company which was acquired by Takeda Pharmaceutical Company in 2005 .
In April 2016 , the U.S. FDA added a warning about increased risk of heart failure .